Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry

Safety and efficacy of well managed warfarin

(2015) Vilhelm Sjögren et al.   THROMBOSIS AND HAEMOSTASIS

‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey

(2014) Gregory Y.H. Lip et al.   AMERICAN JOURNAL OF MEDICINE

Stroke and bleeding risk evaluation in atrial fibrillation: results of the European Heart Rhythm Association survey

(2014) T. B. Larsen et al.   EUROPACE

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force

(2014) Bulent Gorenek et al.   EUROPACE

Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

(2014) G. Y. H. Lip et al.   EUROPACE

Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey

(2014) T. S. Potpara et al.   EUROPACE

Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)

(2014) Gregory Y.H. Lip et al.   EUROPEAN HEART JOURNAL

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation

(2014) Torben Larsen et al.   THROMBOSIS AND HAEMOSTASIS

Patient’s values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation

(2014) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Differences among western European countries in anticoagulation management of atrial fibrillation

(2014) Bettina Ammentorp et al.   THROMBOSIS AND HAEMOSTASIS

Overtreatment and Undertreatment With Anticoagulation in Relation to Cardioversion of Atrial Fibrillation (the RHYTHM-AF Study)

(2013) Gregory Y.H. Lip et al.   AMERICAN JOURNAL OF CARDIOLOGY

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

(2013) Gregory Y.H. Lip et al.   EUROPACE

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

(2013) Pilar Gallego et al.   THROMBOSIS AND HAEMOSTASIS

Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

(2013) Raffaele Caterina et al.   THROMBOSIS AND HAEMOSTASIS

Patient outcomes using the European label for dabigatran

(2013) Andreas Clemens et al.   THROMBOSIS AND HAEMOSTASIS

Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey

(2012) R. Pisters et al.   EUROPACE

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Prognosis and Guideline-Adherent Antithrombotic Treatment in Patients With Atrial Fibrillation and Atrial Flutter

(2011) Laurent Gorin et al.   CHEST

The role of aspirin for stroke prevention in atrial fibrillation

(2011) Gregory Y. H. Lip   Nature Reviews Cardiology

Don’t add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation

(2008) Gregory Y H Lip   BMJ-British Medical Journal